IMITREX sumatriptan succinate - PowerPoint PPT Presentation

1 / 11
About This Presentation
Title:

IMITREX sumatriptan succinate

Description:

What is a Migraine? ... Prior to Triptans, believed that migraines caused by pressure on nerves from ... New era in migraine drugs, 1973 ... – PowerPoint PPT presentation

Number of Views:973
Avg rating:5.0/5.0
Slides: 12
Provided by: UNC9151
Category:

less

Transcript and Presenter's Notes

Title: IMITREX sumatriptan succinate


1
IMITREX(sumatriptan succinate)
  • University of North Carolina at Wilmington
  • By Lauren Varamo, Sara Waltz, Daniel Tozour,
    Kathryn Smith, Robert Trost, James Svetlovics

2
What is a Migraine?
  • Blood vessels of the brain expand, due to a
    decrease in the level of serotonin.
  • This expansion leads to pressure on neighboring
    nerves resulting in severe pain in the head area.
  • Imitrex works by targeting the nerves and blood
    vessels affected by this expansion.

3
Imitrex Discovery
  • The class of drugs called Triptans came onto the
    market in the early 1990s to assist in migraine
    pain
  • Prior to Triptans, believed that migraines caused
    by pressure on nerves from dilated blood vessels.
  • Treated with ergotamines that constrict blood
    vessels Cafergot, Wigraine
  • Lots of side effects, major health risks severe
    coronary artery disease, peripheral vascular
    disease

4
Discovery of Imitrex
  • New era in migraine drugs, 1973
  • Following up on numerous observations implicating
    more selective agonist, serotonin (potent
    vasoconstrictor pain modulator)
  • 1997, GlaxoSmithKline introduced first of new
    serotonin agonists, sumatriptan (Imitrex)

5
Structure
  • Imitrex (Sumatriptan Succinate)

Imitrex (Sumatriptan Succinate)
6
Methods of Administration
  • 24 hr. Period
  • Oral Tablet (max. 200 mg)
  • Injection (max. 12 mg injection/200 mg. oral)
  • Nasal Spray (max. 40 mg)
  • Imitrex only taken at SIGN of migraine, not
    on regular basis. Will NOT prevent future
    migraines!

7
Mechanism of Action
  • Exact mechanism of action is not known at this
    time.
  • Binding Sites
  • -All 5-HT (5 Hydoroxyltryptamine) receptors
  • -Also weakly binds to all subtype receptors
  • h5-HT1D and h5-HT1B

8
Absorption/Distribution/Meta-bolism/Excretion
  • Protein binding very low in the blood stream
    (approx. 14-21)
  • First pass metabolism-enter blood stream and
    metabolized in liver by the A isoenzyme (MAO-A)
    where it undergoes an oxidative deamination
    pathway into an inactive metabolite.
  • 60 renally excreted, other 40 in feces

9
Side Effects/Toxicity
  • Allergic Reactions (swelling, redness, burning,
    numbness, etc.)
  • Long list of less serious side-effects including
    Nausea, Vomiting, Diarrhea, dizziness, drooling,
    etc.
  • Serious side-effects including tightness of
    neck/jaw, fainting, seizures, abdominal pain,
    cold sensation in limbs, etc.
  • Many, Many, Many medications have serious
    interactions with Imitrex (MAOI,
    Anti-depressants, other migraine medications

10
Seritonin Syndrome
  • Between 1998 and 2002 27 cases were reported
    where serotonin syndrome was associated with the
    use of triptans and SSRIs.
  • Two were life threatening
  • Eight were related to incresed doseages

11
Serotonin Syndrome cont
  • 1,000,000 people over 1998-2001 only 27 cases
  • 0.03 have syndrome, 0.002 were life threatening
  • Can occur from SSRIs and SNRIs alone
  • 1,784 patients on SSRIs were given triptans and
    no neurological events were noted.
Write a Comment
User Comments (0)
About PowerShow.com